Clinical Trials Patients Policy State Laws 
Cannabis Law Report
OCTOBER 4, 2021
One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions.
MMJ Recs
MAY 9, 2024
Understanding State Laws: While medical marijuana is legal in many states, the specific regulations governing its use can vary widely. These organizations provide educational resources, assistance with navigating state laws, and support in obtaining medical marijuana cards.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
JANUARY 4, 2019
Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Click here to email your member of Congress and urge them to join the Cannabis Caucus. Pennsylvania.
MMJ Recs
DECEMBER 17, 2023
The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.
Cannabis Law Report
APRIL 21, 2022
Commercialization & Patient Access · Any City, Any State, California. It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. Executive Summary. Key Responsibilities.
NORML
JANUARY 18, 2019
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. KY resident? OK resident? AK resident?
Cannabis Law Report
JULY 14, 2021
ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. In one particular group, all patients showed consistent results across multiple genomic analyses. federal law. Karl Kottmeier” President.
Expert insights. Personalized for you.
52 
Let's personalize your content